Evidence map›Paper›PMID 32072048›Full record

ArticleHeliyon2020

Modulation of bone turnover aberration: A target for management of primary osteoporosis in experimental rat model.

Enas A Fouad-Elhady, Hadeer A Aglan, Rasha E Hassan, Hanaa H Ahmed, Gilane M Sabry

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Enas A Fouad-ElhadyBiochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt.
Hadeer A AglanHormones Department, Medical Research Division, National Research Centre, Giza, Egypt.
Rasha E HassanBiochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt.
Hanaa H AhmedHormones Department, Medical Research Division, National Research Centre, Giza, Egypt.
Gilane M SabryBiochemistry Department, Faculty of Science, Ain Shams University, Cairo, Egypt.
Ain Shams University · EGNational Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis is a skeletal degenerative disease characterised by abnormal bone turnover with scant bone formation and overabundant bone resorption. The present approach was intended to address the potency of nanohydroxyapatite (nHA), chitosan/hydroxyapatite nanocomposites (nCh/HA) and silver/hydroxyapatite nanoparticles (nAg/HA) to modulate bone turnover deviation in primary osteoporosis induced in the experimental model. Characterisation techniques such as TEM, zeta-potential, FT-IR and XRD were used to assess the morphology, the physical as well as the chemical features of the prepared nanostructures. The

Indexed as

Biomedical engineeringBone turnoverChitosan nanoplatformMaterials scienceNanohydroxyapatiteNanotechnologyPrimary osteoporosisSilver nanoparticles

Identifiers

PMID32072048
PMCPMC7011045
OpenAlexW3004925071

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.